POS1216 POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROMES. Amikishiyev, A. Gül, N. Koca et al.|Annals of the Rheumatic Diseases|2022Cited by 6
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19B. İnce, Murat İnanç, Murat Bektaş et al.|JCR Journal of Clinical Rheumatology|2022Cited by 4